Season's Savings | ₹5/mo for 3 months

₹199/month after first 3 months. Renews automatically. Terms apply.
The Great Cancer Test Experiment cover art

The Great Cancer Test Experiment

Preview
Get this deal Free with 30-day trial
Offer ends on 28 December, 2026.
Prime logo
Only ₹5/month for first 3 months.
Get 1 credit per month to use on any title of your choice.
Listen to anything from the Plus Catalogue—thousands of audiobooks, podcasts, and Audible Originals.
₹199/month after first 3 months. Cancel anytime. Renews automatically. Offer ends 28 December, 2026.
1 credit a month to use on any title to download and keep
Listen to anything from the Plus Catalogue—thousands of Audible Originals, podcasts and audiobooks
Download titles to your library and listen offline
₹199.00 per month after 30-day trial. Cancel anytime.

The Great Cancer Test Experiment

Written by: Antonio Reglado
Narrated by: Todd Mundt
Free with 30-day trial Free with 30-day trial

₹199.00 per month after 30-day trial. Cancel anytime.

₹199.00 per month after 30-day trial. Cancel anytime.

Buy Now for ₹165.26

Buy Now for ₹165.26

About this listen
A year ago I interviewed Deborah Fletcher, a 54-year-old manager at Deloitte who was fighting inflammatory breast cancer with all her professional skills. She carried a briefcase of spreadsheets, documenting treatments, bills, research, notes about who'd said what and what her plans were. Like many patients with advanced cancer, Fletcher eventually put her hopes in an experiment. In her case it wasn't a new drug but a new kind of test, called a liquid biopsy. The test scans a person's blood for small fragments of DNA released by tumors. The one she got, from Guardant Health, a California startup heavily financed by venture capitalists, looks for the DNA sequences of 68 well-known cancer genes and can reveal the mutations driving a person's cancer.©Massachusetts Institute of Technology (P)Massachusetts Institute of Technology Science
adbl_web_anon_alc_button_suppression_t1
No reviews yet